参考文献/References:
[1]Georges JL,Loukaci V,Poirier O,et al.Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction:the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde[J].Journal of Molecular Medicine,2001,79(5-6):300-305.[2]Fajar JK,Azharuddin A.The association between interleukin 6 -174 G/C gene polymorphism and the risk of osteoporosis:A meta-analysis[J].Journal of Taibah University Medical Sciences,2016,12(3):212-220.[3]Xu Y,Zhang Y,Ye J.IL-6: A Potential Role in Cardiac Metabolic Homeostasis[J].International Journal of Molecular Sciences,2018,19(9):2474.[4]An PP,Feng LN,Zhang XX,et al.Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis[J].Medicine (Baltimore),2020,99(50):e23659.[5]Duan HX,Chen YY,Shi JZ,et al.Association of IL-6 -174G>C (rs1800795) polymorphism with cervical cancer susceptibility[J].Bioscience Reports,2018,38(5):BSR20181071.[6]González-Castro TB,Hernández-Díaz Y,Pérez-Hernández N,et al.Interleukin 6 (rs1800795) gene polymorphism is associated with cardiovascular diseases:a meta-analysis of 74 studies with 86,229 subjects[J].EXCLI Journal,2019,18:331-355.[7]Yuepeng J,Zhao X,Zhao Y,et al.Gene polymorphism associated with TNF-α (G308A) IL-6 (C174G) and susceptibility to coronary atherosclerotic heart disease: A meta-analysis[J].Medicine (Baltimore),2019,98(2):e13813.[8]Zheng GH,Chen HY,Xiong SQ.Polymorphisms of -174G>C and -572G>C in the interleukin 6 (IL-6) gene and coronary heart disease risk: a meta-analysis of 27 research studies[J].PLoS One,2012,7(4):e34839.[9]Zhang H,Liu C,Zhao B,et al.An Evidence-Based Meta-Analysis on the Roles of Functional Interleukin-6 Polymorphisms in Coronary Artery Disease[J].J Interferon Cytokine Res,2018,38(9):370-377.[10]Salari N,Mansouri K,Hosseinian-Far A,et al.The effect of polymorphisms (174G> C and 572C> G) on the Interleukin-6 gene in coronary artery disease: a systematic review and meta-analysis[J].Genes Environ,2021,43(1):1.[11]Lu S,Wang Y,Wang Y,et al.The IL-6 rs1800795 and rs1800796 polymorphisms are associated with coronary artery disease risk[J].J Cell Mol Med,2020,24(11):6191-6207.[12]Akhter MS,Biswas A,Abdullah SM,et al.Influence of Interleukin-6(IL-6) Promoter Gene Polymorphisms(-174G>C,-572G>C,and-597G>A)on IL-6 Plasma Levels and Their Impact in the Development of Acute Ischemic Stroke in Young Indians[J].Clin Appl Thromb Hemost,2019,25:1076029619854136.[13]Ren H,Zhang Y,Yao Y,et al.Association between the interleukin-6 genetic polymorphism 174?G/C and thrombosis disorder risk:Meta-analysis of 10,549 cases and 19,316 controls[J].Medicine (Baltimore),2016,95(27):e4030.[14]Unal S,Gumruk F,Aytac S,et al.Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) levels and IL-6, TNF-polymorphisms in children with thrombosis[J].J Pediatr Hematol Oncol,2008,30(1):26-31.[15]Kim SK,Chung JH,Kwon OY.Promoter Polymorphism (?174, G/C) of Interleukin-6 and Arterial Thromboembolic Events: A Meta-Analysis. Medical Science Monitor:International Medical Journal of Experimental and Clinical Research[J].Med Sci Monit,2016,22:4345-4353.[16]Wang X,Yan Z,Ye Q.Interleukin-6 gene polymorphisms and susceptibility to liver diseases:A meta-analysis[J].Medicine (Baltimore),2019,98(50):e18408.[17]Jalali R,Vaisi-Raygani A,Zhu J.Interleukin-6-174G/C Polymorphism Contributes to Periodontitis Susceptibility:An Updated Meta-Analysis of 21 Case-Control Studies[J].Dis Markers,2016,2016: 9612421.[18]Chatzopoulos GS,Doufexi AE,Kouvatsi A.Clinical response to non-surgical periodontal treatment in patients with interleukin-6 and interleukin-10 polymorphisms. Scientific Reports[J].Med Oral Patol Oral Cir Bucal,2017,22(4):e446-e457.[19]刘满想,宋春峰,张宝营,等.IL-6–174C/G基因多态性与胃癌易感性的meta分析[J].中国普外基础与临床杂志,2017,24(10):1234-1245.[20]Salman BN,Vahabi S,Biglari A,et al.Correlation of interleukin-6-174 GC and interleukin-6-572 GC gene polymorphisms with periodontal disease in an Iranian population[J].Dental Research Journal,2016,13(4):354-361.[21]温鹏飞,王晓松,张敏,等.IL-6基因单核苷酸多态性与系统性红斑狼疮的相关性研究[J].中华疾病控制杂志,2014,18(4):277-280.[22]Ruiz-Padilla AJ,Gamez-Nava JI,Salda?觡a-Cruz AM,et al.The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis[J].Biomed Res Int,2016,2016:4193538. [23]Zhai K,Yang Y,Gao ZG,et al.Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer[J].Oncotarget,2017,8(27):44490-44497.[24]Wang Y,Chen X,Chen Y.Interleukin-6 gene -572G/C polymorphism and prostate cancer risk[J].African Health Sciences,2018,18(2):267-272.[25]Zhao Q,Jin M,Zhang DW,et al.Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children[J].J Cell Mol Med,2018,131(9):1075-1078.[26]Rezaei F,Mohammadi H,Heydari M,et al.Association betweenIL-8 (-251T/A)andIL-6 (-174G/C)Polymorphisms and Oral Cancer Susceptibility: A SystematicReview and Meta-Analysis[J].Medicina (Kaunas),2021,57(5):405.[27]Aleagha OE,Oltulu P,Sadeghi M.Association between interleukin 6 polymorphisms (rs1800796,rs1800795,rs2069837, rs17147230,and rs1800797) and hepatocellular carcinoma susceptibility:a meta-analysis[J].Clinical and Experimental Hepatology,2020,6(4):359-366.[28]Zhao X,Jiang Y,Ping Y,et al.Associations between tumor necrosis factor-α and interleukin-6 polymorphisms and unexplained recurrent spontaneous abortion risk: A meta-analysis[J].Medicine (Baltimore),2019,98(46):e17919.[29]Chen L,Zhang Z,Huang J,et al.Association between rs1800795 polymorphism in the interleukin-6 gene and the risk of polycystic ovary syndrome:A meta-analysis[J].Medicine (Baltimore),2018,97(29):e11558.[30]Lorente L,Martín MM,Pérez-Cejas A,et al.Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients[J].International Journal of Molecular Sciences,2016,17(11):1861.
相似文献/References:
[1]余 亮,谭自明,张 斌,等.甘露糖结合凝集素基因多态性与结核病易感性关系的研究[J].医学信息,2018,31(13):65.[doi:10.3969/j.issn.1006-1959.2018.13.019]
YU Liang,TAN Zi-ming,ZHANG Bin,et al.Relationship between Polymorphism of Mannose Binding Lectin Gene and Susceptibility to Tuberculosis[J].Medical Information,2018,31(12):65.[doi:10.3969/j.issn.1006-1959.2018.13.019]
[2]曾 意,汤永红,张 平.CYP2C19基因多态性与复发性缺血性卒中关系的研究[J].医学信息,2022,35(11):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
ZENG Yi,TANG Yong-hong,ZHANG Ping.Study on Correlation Between CYP2C19 Gene Polymorphism and Recurrent Ischemic Stroke[J].Medical Information,2022,35(12):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
[3]王在川,华 琳.SOD基因多态性与COPD易感性的Meta分析[J].医学信息,2018,31(17):57.[doi:10.3969/j.issn.1006-1959.2018.17.018]
WANG Zai-chuan,HUA Lin.Meta-analysis of SOD Gene Polymorphism and Susceptibility to COPD[J].Medical Information,2018,31(12):57.[doi:10.3969/j.issn.1006-1959.2018.17.018]
[4]朱红涛,丁振江,赵媛媛.CYP2C19基因多态性与氯吡格雷抵抗的相关性研究[J].医学信息,2020,33(08):40.[doi:10.3969/j.issn.1006-1959.2020.08.014]
ZHU Hong-tao,DING Zhen-jiang,ZHAO Yuan-yuan,et al.Correlation Between CYP2C19 Gene Polymorphism and Clopidogrel Resistance[J].Medical Information,2020,33(12):40.[doi:10.3969/j.issn.1006-1959.2020.08.014]
[5]陈启松,何海军,谷光敏,等.IL-6基因多态性与心房颤动相关性的Meta分析[J].医学信息,2020,33(23):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
CHEN Qi-song,HE Hai-jun,GU Guang-min,et al.Meta Analysis of the Correlation Between IL-6 Gene Polymorphism and Atrial Fibrillation[J].Medical Information,2020,33(12):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
[6]邓顺顺,平军娇,章 杰,等.APOE基因多态性与精神分裂症的相关性研究[J].医学信息,2023,36(06):110.[doi:10.3969/j.issn.1006-1959.2023.06.024]
DENG Shun-shun,PING Jun-jiao,ZHANG Jie,et al.Study on the Correlation Between APOE Gene Polymorphism and Schizophrenia[J].Medical Information,2023,36(12):110.[doi:10.3969/j.issn.1006-1959.2023.06.024]
[7]张莹莹,郭绪昆,刘 寅.氯吡格雷药代动力学特点及其在心血管疾病中的临床应用[J].医学信息,2021,34(20):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
ZHANG Ying-ying,GUO Xu-kun,LIU Yin.Pharmacokinetic Characteristics of Clopidogrel and the Clinical Application in Cardiovascular Diseases[J].Medical Information,2021,34(12):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
[8]赵鑫龙,杨杰孚.华法林药物基因组学的应用[J].医学信息,2021,34(20):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
ZHAO Xin-long,YANG Jie-fu.Application of Warfarin Pharmacogenomics[J].Medical Information,2021,34(12):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
[9]汪 青,钱胤华,钱平康,等.基于生物信息学的肩袖撕裂与绝经后骨质疏松症的共病研究[J].医学信息,2023,36(15):6.[doi:10.3969/j.issn.1006-1959.2023.15.002]
WANG Qing,QIAN Yin-hua,QIAN Ping-kang,et al.Study on the Comorbidity of Rotator Cuff Tear and Postmenopausal Osteoporosis Based on Bioinformatics[J].Medical Information,2023,36(12):6.[doi:10.3969/j.issn.1006-1959.2023.15.002]
[10]郁德波,林志雄,林举达.MAOA基因与精神分裂症的关系研究[J].医学信息,2023,36(16):189.[doi:10.3969/j.issn.1006-1959.2023.16.039]
YU De-bo,LIN Zhi-xiong,LIN Ju-da.Study on the Relationship Between MAOA Gene and Schizophrenia[J].Medical Information,2023,36(12):189.[doi:10.3969/j.issn.1006-1959.2023.16.039]